Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USP 20 mg
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
- Products
-
- Duloxetine Delayed-Release Capsules USP 20 mg
- Company
- Rising Pharma Holding, Inc.
- Where it was sold
-
Nationwide
Nationwide
- Units affected
- 73,680 bottles
- About this recall
- Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ NDC 57237-017-60